TrialJournal of atherosclerosis and thrombosis2025

Clinical Pharmacology of Pemafibrate Extended-release Formulation in Patients with Hypertriglyceridemia-A Phase 2, Multicenter, Active-controlled, Randomized, Single-blind, Crossover study.

Shizuya Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.